Morito Monden

发表

Interleukin-6 as a new indicator of inflammatory status: detection of serum levels of interleukin-6 and C-reactive protein after surgery.

A. Ogata, T. Kishimoto, H. Tagoh, 1992, Surgery.

The status of Fas and Fas ligand expression can predict recurrence of hepatocellular carcinoma

H. Eguchi, K. Dono, H. Nagano, 2000, British Journal of Cancer.

Augmentation of antitumor activity of 5-fluorouracil by interferon alpha is associated with up-regulation of p27Kip1 in human hepatocellular carcinoma cells.

H. Eguchi, M. Monden, K. Dono, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Expression and clinical significance of erb-B receptor family in hepatocellular carcinoma

M. Monden, N. Matsuura, S. Higashiyama, 2001, British Journal of Cancer.

Hemostasis activation during sclerotherapy of lower extremity varices.

M. Monden, T. Nakamura, J. Kambayashi, 1996, Thrombosis research.

Signal transduction system in epinephrine stimulated platelets; comparison between epinephrine sensitive and insensitive platelets.

M. Monden, T. Nakamura, J. Kambayashi, 1997, Thrombosis research.

Extracellular calcium protects cultured rat hepatocytes from injury caused by hypothermic preservation.

K. Umeshita, T. Mori, Morito Monden, 1988, Cryobiology.

PGI2 analogue, sodium beraprost, suppresses superoxide generation in human neutrophils by inhibiting p47phox phosphorylation.

M. Monden, M. Sakon, J. Kambayashi, 1995, Life sciences.

The tumor suppressor protein APC colocalizes with beta-catenin in the colon epithelial cells.

T. Akiyama, M. Monden, I. Miyashiro, 1996, Biochemical and biophysical research communications.

Expression level of valosin-containing protein (VCP) as a prognostic marker for gingival squamous cell carcinoma.

M. Kogo, M. Monden, H. Inohara, 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

Muscle undergoes atrophy in association with increase of lysosomal cathepsin activity in interleukin-6 transgenic mouse.

M. Monden, T. Morimoto, E. Kominami, 1995, Biochemical and biophysical research communications.

Distinct actions and cooperative roles of ROCK and mDia in Rho small G protein-induced reorganization of the actin cytoskeleton in Madin-Darby canine kidney cells.

M. Monden, A. Mammoto, H. Shiozaki, 1999, Molecular biology of the cell.

Rho and Rab small G proteins coordinately reorganize stress fibers and focal adhesions in MDCK cells.

T. Sasaki, M. Monden, H. Shiozaki, 1998, Molecular biology of the cell.

Evaluation of the technical difficulty performing laparoscopic resection of a rectosigmoid carcinoma: visceral fat reflects technical difficulty more accurately than body mass index

M. Monden, I. Takemasa, M. Ikeda, 2007, Surgical Endoscopy.

Significance of RRM1 and ERCC1 expression in resectable pancreatic adenocarcinoma

Y. Takeda, G. Bepler, Y. Doki, 2009, Oncogene.

Quantitative evaluation of vimentin expression in tumour stroma of colorectal cancer

M. Monden, C. Ngan, H. Yamamoto, 2007, British Journal of Cancer.

Activation of c-Src gene product in hepatocellular carcinoma is highly correlated with the indices of early stage phenotype.

M. Monden, H. Nagano, K. Wakasa, 2001, Journal of hepatology.

Investigation of the oxytocin receptor expression in human breast cancer tissue using newly established monoclonal antibodies.

M. Monden, N. Matsuura, C. Azuma, 1996, Endocrinology.

Expression of PPARδ in multistage carcinogenesis of the colorectum: implications of malignant cancer morphology

M. Monden, C. Ngan, H. Yamamoto, 2006, British Journal of Cancer.

Clinical significance of micrometastases in axillary lymph nodes assessed by reverse transcription-polymerase chain reaction in breast cancer patients.

I. Sakita, M. Ooka, M. Kadota, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Assessment of Stanniocalcin-1 mRNA as a molecular marker for micrometastases of various human cancers.

M. Monden, A. Miyamoto, H. Nagano, 2000, International journal of oncology.

Expression of truncated midkine in human colorectal cancers.

T. Akiyama, M. Monden, I. Miyashiro, 1996, Cancer letters.

Nonpalpable breast cancer with nipple discharge: how should it be treated?

M. Monden, Y. Tamaki, I. Miyashiro, 1997, Anticancer research.

Analysis of phosphorylation of pRB and its regulatory proteins in breast cancer.

M. Monden, Y. Tamaki, I. Miyashiro, 1997, Journal of clinical pathology.

Expression of p21 (WAF1/CIP1) protein in clinical thyroid tissues.

M. Monden, Y. Tamaki, N. Matsuura, 1996, British Journal of Cancer.

Cyclin D1 overexpression in esophageal dysplasia: a possible biomarker for carcinogenesis of esophageal squamous cell carcinoma.

Y. Doki, M. Yano, M. Monden, 2000, International journal of oncology.

A detailed analysis of the role of K-ras gene mutation in the progression of colorectal adenoma.

M. Monden, H. Yamamoto, K. Takami, 1997, British Journal of Cancer.

Effector cells in allelic H-2 class I-incompatible skin graft rejection

A. Uenaka, T. Ichikawa, Morito Monden, 1987, The Journal of experimental medicine.

Hypercholesterolemia as a risk factor for deep-vein thrombosis.

M. Monden, M. Sakon, J. Kambayashi, 1997, Thrombosis research.

Platelet microparticles: a carrier of platelet-activating factor?

M. Monden, J. Kambayashi, T. Kawasaki, 1996, Biochemical and biophysical research communications.

alpha-catenin-independent recruitment of ZO-1 to nectin-based cell-cell adhesion sites through afadin.

K. Irie, M. Monden, K. Tachibana, 2001, Molecular biology of the cell.